These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34909070)

  • 1. Adverse events following immunization reporting and impact on immunization services in informal settlements in Nairobi, Kenya: a prospective mixed-methods study.
    Malande OO; Munube D; Afaayo RN; Chemweno C; Nzoka M; Kipsang J; Musyoki AM; Meyer JC; Omayo LN; Owino-Okongo L
    Pan Afr Med J; 2021; 40():81. PubMed ID: 34909070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of adverse events following pentavalent and diphtheria-tetanus-pertussis vaccines among Nigerian children.
    Sadoh AE; Nwaneri DU; Ogboghodo BC; Sadoh WE
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):119-122. PubMed ID: 28585776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
    Christou-Ergos M; Wiley KE; Leask J
    Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.
    Wang C; Huang N; Lu QB; Black S; Liang X; Cui F
    Front Immunol; 2022; 13():956473. PubMed ID: 36248783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety monitoring of a new pentavalent vaccine in the expanded programme on immunisation in Ghana.
    Dodoo AN; Renner L; van Grootheest AC; Labadie J; Antwi-Agyei KO; Hayibor S; Addison J; Pappoe V; Appiah-Danquah A
    Drug Saf; 2007; 30(4):347-56. PubMed ID: 17408311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005-2017.
    Yoon D; Kim JH; Lee H; Shin JY
    Yonsei Med J; 2020 Jul; 61(7):623-630. PubMed ID: 32608206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone "beep" in a Cameroon health district: a randomized field trial.
    Tsafack M; Ateudjieu J
    Pan Afr Med J; 2015; 22():351. PubMed ID: 26985269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization.
    Muñoz CE; MacDonald B; Pham-Huy A; Vaudry W; Pernica JM; Boucher FD; Constantinescu C; Sadarangani M; Bettinger JA; Tapiéro B; Morris SK; McConnell A; Cowan J; Zafack J; Upton J; Abdurrahman Z; McHenry M; Hildebrand KJ; Noya F; De Serres G; Halperin SA; Top KA;
    J Pediatr; 2022 Nov; 250():45-53.e3. PubMed ID: 35948192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana.
    Yamoah P; Mensah KB; Padayachee N; Bangalee V; Oosthuizen F
    Hum Vaccin Immunother; 2023 Dec; 19(1):2199654. PubMed ID: 37127290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
    Kant A; Jansen J; van Balveren L; van Hunsel F
    Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan-and the effects of vaccine hesitancy and government policy.
    Inokuma Y; Kneller R
    Eur J Clin Pharmacol; 2023 Feb; 79(2):269-278. PubMed ID: 36527455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events following immunization: real causality and myths.
    Principi N; Esposito S
    Expert Opin Drug Saf; 2016 Jun; 15(6):825-35. PubMed ID: 26986067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following immunization in children: retrospective analysis of spontaneous reports over a decade.
    Aagaard L; Hansen EW; Hansen EH
    Eur J Clin Pharmacol; 2011 Mar; 67(3):283-8. PubMed ID: 21079934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014-19.
    Stefanizzi P; Bianchi FP; Spinelli G; Amoruso F; Ancona D; Stella P; Tafuri S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-6. PubMed ID: 34435938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the adverse events following immunization surveillance system in Guruve district, Mashonaland Central 2017.
    Constantine M; Cremance T; Juru TP; Gerald S; Notion GT; Peter N; Mufuta T
    Pan Afr Med J; 2018; 31():202. PubMed ID: 31452827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
    Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
    BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions following immunization with MMR vaccine in children at selected provinces of Iran.
    Esteghamati A; Keshtkar A; Heshmat R; Gouya MM; Salar Amoli M; Armin S; Mahoney F
    Arch Iran Med; 2011 Mar; 14(2):91-5. PubMed ID: 21361714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.